Denali Therapeutics Exercises Option to Acquire F-Star Gamma

By Natasha Piper

Pharma Deals Review: Vol 2018 Issue 6 (Table of Contents)

Published: 28 Jun-2018

DOI: 10.3833/pdr.v2018.i6.2332     ISSN: 1756-7874

Section: Mergers & Acquisitions



Committed to defeating neurogenerative disease, Denali Therapeutics has exercised an option to acquire F-Star Gamma for US$24 M as well as potential milestone payments of up to US$447 M...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details